Chronic Diseases Journal
January 30, 2023
Fatemeh Yousefzadeh
BACKGROUND: Mindfulness-based cognitive therapy (MBCT) is an effective psychological approach for chronic mood disorders. This study was conducted to examine the effectiveness of MBCT on depression and anxiety in women with systemic lupus erythematous (SLE) within a 3-month follow-up. METHODS: This study was quasi-experimental with pretest-posttest design and control group. Study population...
Advances in Research
January 30, 2023
Jennings Hernandez
Roughly over 700 million individuals suffer from a mental illness globally. In the United States alone, over 45 million individuals are afflicted with a mental disorder at any given point in their lives. It is because of this that new methods of current therapies should be considered. To date, major depression disorder (MAD), anxiety, and post-traumatic stress disorder (PTSD) are treated with...
Healthcare
January 26, 2023
Maggie Lawrence, Bridget Davis, Leyla De Amicis et al.
Background: Following stroke, rates of mood disorder are and remain high at five years (anxiety 34.4%; depression 23%). Structured mindfulness-based stress reduction (MBSR) courses are effective in a range of health conditions, but stroke survivors find adherence challenging. We aimed to adapt a standard MBSR course specifically for people affected by stroke. Methods: We recruited stroke...
Journal of Multilingual and Multicultural Development
January 24, 2023
Xiaojuan Gao
39 citations
Mindfulness has been overlooked in previous studies of second or foreign language learning. This study aims to explore the relationship between mindfulness, anxiety, burnout and self-perceived foreign language proficiency among a sample of 492 learners. Further, it seeks to make up for the deficiency in the current empirical literature regarding the mediation roles of anxiety and burnout in the...
Nursing Open
January 24, 2023
Hui Liu, L. Kong, Qian Sun et al.
This meta‐analysis aimed to determine the effect of mindfulness interventions on nurses' levels of depression and anxiety.
Cancer Nursing
January 23, 2023
Bixia Zhang, Xiaohuan Jin, X. Kuang et al.
Background Emerging evidence supports that virtual reality (VR)–based meditation interventions may improve anxiety and depression among patients with cancer. However, empirical studies involving patients with acute leukemia during induction chemotherapy are limited. Objective This study aimed to examine the effects of VR-based meditation intervention on alleviating anxiety and depression and...
Journal of Neuroscience
January 18, 2023
Xiao Han, Ying Liang, Briana J. Hempel et al.
Cannabinoids modulate dopamine (DA) transmission and DA-related behavior, which has been thought to be mediated initially by activation of cannabinoid CB1 receptors (CB1Rs) on GABA neurons. However, there is no behavioral evidence supporting it. In contrast, here we report that CB1Rs are also expressed in a subset of DA neurons and functionally underlie cannabinoid action in male and female...
Journal of Psychedelic Studies
January 18, 2023
Benjamin R. Lewis, Kevin Byrne, John Hendrick et al.
22 citations
Abstract Background Psilocybin-assisted psychotherapy has demonstrated significant promise as a treatment for depression, anxiety, and existential distress associated with serious medical illness and has generally been employed on an individual basis, which presents challenges for scaling and resource availability. There are also compelling theoretical reasons to suggest that group-based...
medRxiv
January 17, 2023
Ryan Yermus, Michael Verbora, Sidney H. Kennedy et al.
2 citations
preprint
Abstract IMPORTANCE Ketamine-Assisted Psychotherapy (KAP) is an emerging treatment option to alleviate treatment resistant affective disorders, but its long term effectiveness remains unclear. OBJECTIVE To examine the treatment effects of KAP on anxiety, depression, and post traumatic stress disorder (PTSD) at 1, 3, and 6 months post treatment. DESIGN, SETTING, AND PARTICIPANTS This...
AIDASCO Reviews
January 17, 2023
Dragana Marković, Eleonora Čapelja
2 citations
Major depressive disorder (MDD), also known as clinical depression, is a serious mental disorder and ranks first among psychiatric disorders that dominate the global disease burden. Recently, it was found that psilocybin, active compound derived from psychotropic mushrooms, can relieve depression symptoms rapidly and sustained benefits for several months. Beside MDD, psilocybin can alleviate...
Scientific Reports
January 13, 2023
Thomas Schnell, Christina-Marie Grömm, Nils Klöckner
3 citations
Cannabis use is a common risk factor for psychoses. But although prevalence of consumption as well as potency of cannabis increased, the incidence of schizophrenia remained stable. The discontinuation hypothesis suggests that a potential increase of psychoses incidence may be relativized by more frequent cessation of consumption due to higher rates of adverse psychosis-like intoxication effects...
Bipolar Disorders
January 13, 2023
Giovanni Martinotti, Bernardo Dell’osso, Giorgio Di Lorenzo et al.
72 citations
BACKGROUND: Bipolar depression accounts for most of the disease duration in type I and type II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals do not respond to first-line therapeutic options, resulting in treatment-resistant bipolar depression (B-TRD). Esketamine, the S-enantiomer of ketamine, has recently been approved for treatment-resistant...
Brain Sciences
January 13, 2023
Maria Gałuszko‐węgielnik, Zuzanna Chmielewska, Katarzyna Jakuszkowiak‐wojten et al.
20 citations
Psychotic treatment-resistant depression is a complex and challenging manifestation of mood disorders in the clinical setting. Psychotic depression is a subtype of major depressive disorder characterized by mood-consistent hallucinations and/or delusions. Psychotic depression is often underdiagnosed and undertreated. Ketamine appears to have rapid and potent antidepressant effects in clinical...
Annals of Pharmacotherapy
January 12, 2023
C Michael White, Nissen Weisman, Joseph Dalo
18 citations
Objective: To assess the role of psychedelics in the treatment of anxiety or depression among patients with cancer. Data Sources: PubMed search from inception to March 11, 2022, using the terms anxiety, depression, psychedelics, psilocybin, lysergic acid, methylenedioxymethamphetamine, or ayahuasca. Study Selection and Data Extraction: Studies assessing patients with cancer receiving...
Frontiers in Psychiatry
January 10, 2023
Jennifer Warner-Schmidt, Christopher Pittenger, Martin Stogniew et al.
11 citations
Introduction Selective serotonin reuptake inhibitor (SSRI) antidepressants represent first-line pharmacological treatment for a variety of neuropsychiatric illnesses, including major depressive disorder (MDD), anxiety, and post-traumatic stress disorder (PTSD), which show high rates of comorbidity. SSRIs have a delayed onset of action. Most patients do not show significant effects until 4–8...
Anxiety, Stress, and Coping
January 9, 2023
E. C. Wolfe, Andrew G. Thompson, T. Brunyé et al.
ABSTRACT Background and Objectives We examined the effects of ultra-brief training in mindfulness and cognitive reappraisal on affective response and performance under stress. We hypothesized that one or both types of training would decrease affective responding and improve performance, and that these effects might be moderated by acute stress induction. Design We manipulated training...
Frontiers in Psychiatry
January 9, 2023
Abdullah Al Ozairi, Dalal Alsaeed, Ebaa Al-Ozairi et al.
Background: The outbreak of coronavirus disease 2019 (COVID-19) created unprecedented stress on physicians. Mindfulness is a type of meditation that focuses on being fully present, aware of senses, and emotions in the present moment without analyzing or judging them, and it may help reduce psychological distress in physicians. This study aimed to examine the effectiveness of virtual...
Frontiers in Public Health
January 9, 2023
Hongyang Liu, Kexin Cai, Jinyang Wang et al.
BackgroundMindfulness-based interventions (MBIs) are psychological interventions widely used in menopausal women. Currently, there is no evidence summary on the effectiveness of MBIs on anxiety, depression, stress, and mindfulness in menopausal women. This meta-analysis examines the effectiveness of MBIs in improving anxiety, depression, stress, and mindfulness scores in menopausal...
Biomedicines
January 6, 2023
Matija Šestan-Peša, Marya Shanabrough, Tamás L. Horváth et al.
4 citations
As marijuana use during adolescence has been increasing, the need to understand the effects of its long-term use becomes crucial. Previous research suggested that marijuana consumption during adolescence increases the risk of developing mental illnesses, such as schizophrenia, depression, and anxiety. Ghrelin is a peptide produced primarily in the gut and is important for feeding behavior....
Frontiers in Psychology
January 6, 2023
Jun Yu Li, Can Xu, Keyan Wan et al.
Mindfulness-based interventions are found to have a positive effect on an individual’s mental health. Using a meta-analysis method, this study examined the effects of mindfulness-based interventions on alleviating anxiety among Chinese college students. Using six international and two Chinese electronic databases, we comprehensively researched literature published between 1 January 2012 and 31...